Related Experiment Video
Updated: Feb 25, 2026

In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein
Published on: January 2, 2015
Untangling the tauopathies: Current concepts of tau pathology and neurodegeneration
1Queen Square Brain Bank for Neurological Disorders, UCL Institute of Neurology, University College London, London, UK; Reta Lila Weston Institute for Neurological Studies, UCL Institute of Neurology, London, UK; Department of Molecular Neuroscience, UCL Institute of Neurology, University College London, London, UK.
Abstract:
Tau is the most common misfolded protein responsible for human neurodegenerative diseases. The identification of mutations in MAPT, the gene that encodes tau, causing dementia and parkinsonism established the notion that tau aggregation is responsible for the development of disease. An increased understanding of the pathway leading from conformational changes in tau protein and tau propagation to neuronal dysfunction, cell death and clinical manifestation will be the key for the development mechanism-based therapeutic strategies for tauopathies.
More Related Videos
Related Concept Videos
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Parkinson's Disease: Overview
Dementia
The progression of dementia is generally gradual....
Long-term Depression
Calcium Ion Concentration Mechanism
If over...
Long-term Depression
Alzheimer's Disease: Treatment

